Attention-deficit/hyperactivity disorder in India: epidemiology, diagnostic inequities, treatment gaps, and public mental health implications - Takeaways - MDSpire

Attention-deficit/hyperactivity disorder in India: epidemiology, diagnostic inequities, treatment gaps, and public mental health implications

  • By

  • Althaf Mahin

  • Bristow Ben Joseph

  • Fathimathul Sunaina

  • Fathimathu Rasana

  • Rajesh Raju

  • June 16, 2026

  • 0 min

Share

  • 1

    ADHD is a prevalent neurodevelopmental disorder in India, with significant regional variations in prevalence estimates due to diagnostic practices and healthcare access.

  • 2

    Access to specialist evaluation and treatment for ADHD remains uneven in India, particularly in rural and underserved areas, leading to underdiagnosis.

  • 3

    Current management strategies for ADHD in India emphasize a multimodal approach, yet treatment access is hindered by financial and infrastructural barriers.

  • 4

    Environmental factors, early-life adversity, and lifestyle influences may affect ADHD risk and symptom expression, complicating diagnosis and treatment.

  • 5

    Strengthening epidemiological surveillance and improving equitable access to ADHD services are crucial for enhancing outcomes in the Indian context.

Original Source(s)

Attention-deficit/hyperactivity disorder in India: epidemiology, diagnostic inequities, treatment gaps, and public mental health implications

  • by Althaf Mahin, Bristow Ben Joseph, Fathimathul Sunaina, Fathimathu Rasana, Rajesh Raju

  • June 16, 2026

Related Content

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

Psychologists, Physicians Scarcer in Rural Areas?

National survey data found lower per-capita representation across 23 occupations in nonmetropolitan communities, with the largest workforce differences observed among psychologists, physicians, and surgeons.

Kalmer, a specific based-App intervention for the treatment of Non-suicidal self-injury (NSSI): a technical and usability study in a non-clinical population